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Introduction 
Social prescribing is a catch-all term for non-medical services that aim to prevent worsening 
health for people with long-term health conditions. In recent years locality-based social 
prescribing services have increasingly been developed by health and social care 
commissioners to provide a mechanism for linking patients in primary care with sources of 
social, therapeutic and practical support in the voluntary and community sector. Social 
prescribing is being promoted by the Department of Health and NHS England as a vital 
component in the transformation and integration of health and social care. 
In Rotherham the Social Prescribing Service is delivered by Voluntary Action Rotherham 
(VAR) in partnership with more than 20 local voluntary and community organisations (VCOs). 
It aims to increase the capacity of GPs to meet the non-clinical needs of patients with 
complex long-term conditions (LTCs).The Service was first commissioned as a two-year pilot 
Pilot in 2012. In 2014-15 it was re-commissioned for a further year with an additional 3 years 
of service provision contracted in April 2015 and funded through the Better Care Fund. At its 
core a team of Voluntary and Community Sector Advisors (VCSAs) provide a single gateway 
to voluntary and community support for GPs and Service users. They receive referrals from 
GPs of eligible patients and carers and assess their support needs before referring on to 
appropriate VCS services. The Service also administers a grant funding pot through which a 
'menu' of VCS activities to meet the needs of Service users is commissioned. The service 
covers the whole of the borough of Rotherham and is one of the largest of its kind, as the 
majority of social prescribing activity in the UK has had a much smaller geographic focus 
and has not provided grant funding for additional services. 
The annual evaluation report provides an updated assessment of the social and economic 
impact of the Rotherham Social Prescribing Service between September 2012 and March 
2015. This report provides a summary of the findings from the full report 
Impact on the demand for urgent hospital care 
Using patient-level Hospital Episode Statistics (HES) the evaluation measured Social 
Prescribing Service users' demand for unplanned and urgent hospital care, comparing non-
elective inpatient admissions and Accident and Emergency attendances for the 12 months 
prior to and following their referral to Social Prescribing. The analysis identified an overall 
trend that points to reductions in Service users' demand for urgent care interventions after 
they had been referred to Social Prescribing: 
 non-elective inpatient episodes reduced by seven per cent  non-elective inpatient spells reduced by 11 per cent  Accident and Emergency attendances reduced by 17 per cent. 
When Service users aged over 80 are excluded from the analysis the changes are more 
marked: 
 non-elective inpatient episodes for Service users aged under 80 reduced by 19 per cent  non-elective inpatient spells for Service users aged under 80 reduced by 20 per cent  Accident and Emergency attendances for Service users aged under 80 reduced by 23 
per cent. 
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Social impact 
People with long-term conditions who were referred to the Social Prescribing Service 
experienced improvements in their well-being and made progress towards better self-
management of their condition. Analysis of well-being outcome data showed that, after 3-4 
months, 82 per cent of these Service users, regardless of age or gender, had experienced 
positive change in at least one outcome area. Importantly, when the results were broken 
down by category they showed that progress was made against each outcome measure and 
that a majority of low-scoring patients made progress. 
These findings were reinforced by case study interviews with a number of Social Prescribing 
Service users and providers who identified a range of well-being outcomes as a result of 
being referred to the Social Prescribing Service.  
"I had a lady that I was going to visit, and she went to a craft club…a community thing.  
She was a bit reticent, but she went.  And she ended up…I know she ran one of the 
classes, so she actually stepped up." (Social Prescribing Service provider) 
"It's the talking and the listening that you feel is of benefit…because after you've 
seen them for a couple of weeks, they'll often say things and open up, not necessarily to 
get an answer, but just to air something." (Social Prescribing volunteer) 
"It keeps you going.  It gets you out of the house.  A lot of us live on our own, so it 
gets us out.  Otherwise we'd be stuck at home." (Social Prescribing Service User) 
"Everybody else's life was steaming ahead…if they did bring euthanasia i,…some 
mornings I would probably have took a bit of, not persuading to go, but thinking I ought 
to do.  I didn't feel like dying, but I didn't feel like living either.  So [staff member] 
came along, and I couldn't open my heart to anyone, except I could open my heart to [S 
staff member] through responding to what she was telling me, and making me a more 
positive person.  Because she had this ability to make me feel as if I was 
worthwhile." (Social Prescribing Service User) 
As these quotes illustrate, Social Prescribing is particularly effective at improving well-being 
and reducing social isolation and loneliness for people with long-term conditions, enabling 
them to become more independent and engaged in their community. Social Prescribing has 
also provided people with advice and support to access the welfare benefits that they are 
entitled to. 
Economic and social benefits 
The economic benefits to commissioners have been estimated based on the NHS costs 
avoided that are associated with reductions in the demand for urgent hospital care: 
 the estimated total NHS costs avoided between 2012-15 were more than half a million 
pounds: an initial return on investment of 43 pence for each pound (£1) invested  If the benefits identified are fully sustained over a longer period 
- the costs of delivering the service for a year would be recouped about two and a 
half years 
- the costs avoided after five years could be as high as £1.1 million: a return on 
investment of £1.98 for each pound (£1) invested 
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- if the benefits are sustained but drop-off at a rate of 20 per cent each year they 
could lead to total costs avoided of £0.68 million: a return on investment of £1.22 
for each pound (£1) invested. 
- if the benefits are sustained but drop-off at a rate of 33 per cent each year they 
could lead to total cost reductions of £0.46 million: a return on investment of £0.83 
for each pound (£1) invested. 
The value of Service user's well-being outcomes were estimated using financial proxies and 
techniques associated with social return on investment (SROI) analysis. The estimated value 
of these benefits was between £0.57 million and £0.62 million in the first year following 
engagement with Social Prescribing: greater than the costs of delivering the service. 
Social Prescribing Service users who engage fully with 
VCS provision experience more change than others 
There is growing evidence from the evaluation that Social Prescribing has a greater effect for 
people who are able to engage fully with the Service, in particular those who continue to 
engage with the VCS beyond their initial 'social prescription'. Service users who completed 
their initial referral activity or activities were more likely to see a reduction in their use of 
urgent and emergency care, more likely to experience improvements in their well-being, and 
represent a much larger per-Service user cost-benefit than those who did not engage as fully. 
Within this group the benefits were particularly pronounced for Service users who completed 
their referral activity and continued to engage with the voluntary and community sector once 
this initial activity was complete. This highlights the importance of ensuring that the types of 
people referred to Social Prescribing are those who are able to engage fully in order to 
experience the greatest benefit from the types of service available. 
Key messages from the evaluation 
There are a number of key messages from this evaluation that can inform and shape the 
future development of social prescribing activities in Rotherham and more widely. 
1. The Rotherham Social Prescribing Service is one of the largest and 
highest profile examples of social prescribing in the UK 
By committing more than £1.6 million to Social Prescribing between 2012 and 2015, 
NHS Rotherham CCG and its statutory partners have made a large and long-term 
financial and strategic commitment to Social Prescribing as a mainstream component of 
health provision in the borough. As such, it is one of the largest and highest profile 
examples of social prescribing in the UK and has received national recognition for the 
work being undertaken, and provides an aspirational model of service delivery for other 
parts of the country.  
Central to the Rotherham Social Prescribing model is role of VAR - the local voluntary 
sector infrastructure body - as the single accountable contract holder independent from 
frontline service delivery, and the micro-commissioning of specific social prescribing 
activities from the local voluntary and community sector that enable service users to 
access support that is tailored to their needs. 
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2. In the past three years the Service has engaged with more than 2,000 local 
people with long-term health conditions 
The Service has substantively engaged with more than 2,000 local people with long-
term health conditions since 2012. Grant-funded social prescribing services have 
provided these Service users and their carers with an important first step to engaging 
with community-based services and wider statutory provision that they would not 
otherwise have been aware of or able to access. 
3. There is growing evidence that Social Prescribing can have positive effect 
on the use of urgent and emergency health services 
Overall, Social Prescribing users had fewer non-elective inpatient episodes and spells 
and fewer Accident and Emergency attendances in the 12 months following their 
engagement with the Service than in the 12 months prior to engagement. However, at 
this moment it is not possible to fully attribute these reductions to Social Prescribing 
interventions due to the absence of a suitable control or comparator group. 
4. Social Prescribing impacts positively on people's well-being 
There is overwhelming quantitative and qualitative evidence that people receive an 
immediate boost to their well-being following their engagement with Social Prescribing, 
and the qualitative longitudinal evidence suggests that these benefits are sustainable. 
Social Prescribing appears to be particularly effective at reducing social isolation and 
loneliness for people with long-term conditions, enabling them to become more 
independent and engaged in their community 
5. There are number of cost-benefits to Social Prescribing, but the effect of 
these should be understood over a long-term timeframe 
Overall, Social Prescribing Service users used fewer NHS urgent care resources in the 
12 months following their engagement with the Service when compared to the previous 
12 months. Across the first three years of the service this reduction equates to 
estimated NHS costs avoided of more than half a million pounds: an initial return on 
investment of 43 pence for each pound (£1) invested. However, these reductions would 
need to be sustained for at least two and a half years for the cost of delivering the 
Service to be recouped. 
The social benefits to Service users accrue a faster rate. The estimated social value of 
the well-being benefits experienced by Service users was between £0.57 million and 
£0.62 million in the first year following engagement with Social Prescribing: greater than 
the costs of delivering the service. 
6. There is growing evidence that Social Prescribing has a greater effect for 
people who are able to engage fully, and who continue to engage with the 
VCS beyond their initial 'social prescription' 
The analysis undertaken for this report has consistently indicated that Service users 
whose engagement with Social Prescribing is most extensive are more likely to 
experience the benefits. Service users who completed their initial referral activity or 
activities are more likely to see a reduction in their use of urgent and emergency care, 
more likely to experience improvements in their well-being, and represent a much larger 
per-Service user cost-benefit than those who do not engage as fully. Within this group 
the benefits are particularly pronounced for Service users who completed their referral 
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activity and continued to engage with the voluntary and community sector once this 
initial activity was complete. 
This highlights the importance of the Social Prescribing Service and key referral points, 
particularly Case Management Teams, working to ensure that the types of people 
referred to Social Prescribing are those who are able to experience the greatest benefit 
from the types of service available. 
7. There are a number of wider benefits and outcomes for the local voluntary 
and community sector associated with the Rotherham Social Prescribing 
Service that mean it provides considerable added value 
Previous evaluation reports have highlighted the benefits of Social Prescribing for the 
local voluntary and community sector: the additional grant funding has improved 
organisational sustainability and enabled additional income to be generated from 
external sources including grant funders and national statutory bodies. More generally, 
the success of the Social Prescribing Service has demonstrated the ability of relatively 
small voluntary and community organisations to make a positive contribution to local 
strategic health and well-being priorities and improved the credibility of the sector with 
statutory partners. 
8. Next steps for evaluation 
Ongoing evaluation will need to track Social Prescribing Service users for a longer 
period post-referral. Although Service users need to be tracked for a minimum of 12 
months post-referral to identify the immediate benefits of Social Prescribing, there is 
merit in tracking Service users for a longer period (at least 2-3 years) to understand the 
extent to which benefits drop-off, are sustained, or are enhanced. In addition, the 
development of a control or comparison group would improve the statistical reliability of 
any data analysis and should be a priority for future evaluative work. The Evaluation 
Team is currently exploring how national Hospital Episodes Statistics can be obtained 
and used to provide a matched-comparator for further analysis. Other areas future 
evaluation might consider include the impact on GP time, use of social and residential 
care and the introduction of a standardised measure of health-related quality of life. 
